Nasdaq - After-hours US$ 4.03 = AU 54c.....
Same old traders story I'm afraid. 'Buy the rumour - sell the fact'.
Its frustrating to watch - even for an IMM old timer like me. For a biotech in late stage trials (multiple P2 trials and about to embark on P3 after successful data) our market cap - $500m is woeful. Why is this? $100m in the bank too.
Several other ASX biotechs in the oncology space, at a much earlier clinical stage have a significantly higher MC.
It could be that Lag-3 and efti has taken a very long time to get to this stage of its clinical development and interest is in other up and coming novel treatments?
TBH - I've given up realising any reasonable/significant gain until Big Pharma put their hand in their pocket - if that ever happens of course! Competitive tension has a limit before the elastic snaps....
Totally p'd off - apologies.....
Nasdaq - After-hours US$ 4.03 = AU 54c.....Same old traders...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.3¢ |
Change
0.008(1.90%) |
Mkt cap ! $562.6M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.3¢ | 39.5¢ | $156.4K | 392.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 122079 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 74609 | 7 |
View Market Depth
| Last trade - 10.33am 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |